XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)-Reference-Cited by-同舟云学术

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)

Published:2022-02-25 Issue:4 Volume:42 Page:314-326
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Zhu Xiao‐Dong¹²,Huang Ming‐Zhu¹²,Wang Yu‐Sheng³,Feng Wan‐Jing¹²,Chen Zhi‐Yu¹²,He Yi‐Fu⁴,Zhang Xiao‐Wei¹²,Liu Xin¹²,Wang Chen‐Chen¹²,Zhang Wen¹²,Ying Jie‐Er⁵,Wu Jun⁶,Yang Lei⁷,Qin Yan‐Ru⁸,Luo Jian‐Feng⁹,Zhao Xiao‐Ying¹²,Li Wen‐Hua¹²,Zhang Zhe¹²,Qiu Li‐Xin¹²,Geng Qi‐Rong¹²,Zou Jian‐Ling¹²,Zhang Jie‐Yun¹²,Zheng Hong¹⁰,Song Xue‐Feng³,Wu Shu‐Sheng⁴,Zhang Cheng‐Yan³,Gong Zhe¹²,Liu Qin‐Qin¹²,Wang Xiao‐Feng⁸,Xu Qi⁵,Wang Qi⁶,Ji Jian‐Mei⁷,Zhao Jian³,Guo Wei‐Jian¹²

Affiliation:

1. Department of Gastrointestinal Medical Oncology Fudan University Shanghai Cancer Center Shanghai 200032 P. R. China

2. Department of Oncology Shanghai Medical College Fudan University Shanghai 200032 P. R. China

3. Department of Gastroenterology Shanxi Cancer Hospital Taiyuan Shanxi 030013 P. R. China

4. Department of Medical Oncology The First Affiliated Hospital Division of Life Science and Medicine University of Science and Technology of China Hefei Anhui 230031 P. R. China

5. Department of Abdominal Medical Oncology Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Cancer and Basic Medicine (IBMC) Chinese Academy of Sciences Hangzhou Zhejiang 310005 P. R. China

6. Department of Medical Oncology The First People's Hospital of Changzhou Changzhou Jiangsu 213004 P. R. China

7. Department of Gastroenterology Nantong Tumor Hospital Nantong Jiangsu 226006 P. R. China

8. Department of Oncology Zhengzhou University First Affiliated Hospital Zhengzhou Henan 450052 P. R. China

9. Department of Biostatistics School of Public Health Fudan University Shanghai 200032 P. R. China

10. Department of medical oncology Cancer Hospital of Fudan University Minhang Branch Shanghai 200032 P. R. China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12278

Reference28 articles.

1. MUC4 , MUC16 , and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer

2. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

3. Palliative chemotherapy for advanced gastric cancer

4. Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute therapy-related myelodysplastic syndromes following capecitabine and oxaliplatin therapy in gastric malignant tumor: A case report;Medicine;2024-07-26

2. Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials;Current Medical Research and Opinion;2024-07-13

3. Correlation between postoperative chemotherapy regimen and survival in patients with resectable gastric adenocarcinoma accompanied with vascular cancer thrombus;World Journal of Gastrointestinal Surgery;2024-06-27

4. Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial;Nature Medicine;2024-06-01

5. LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-Myc protein translation and an energy metabolism positive feedback loop;Cell Death & Disease;2024-03-29